Gemcitabine Injection Ip

Name: Gemcitabine Injection Ip
Brand: DRUGS AND DEVICES PHARMA PRIVATE LIMITED
Price: 2350.0 INR
Availability: InStock

Price 2350.0 INR/ Vial

Get a Price/Quote

MOQ : 4 Vials

Gemcitabine Injection Ip Specification

Life Span
Refer to expiry date on pack

Brand Name
AMGICIN-1000

Pacakaging (Quantity Per Box)
1 vial per box

Salt Composition
Gemcitabine

Origin of Medicine
India

Dosage Form
Injection

Packaging Type
Vial

Indication
Cancer Treatment

Drug Type
Other

Ingredients
Gemcitabine IP

Physical Form
Other

Function
Other

Recommended For
Ovarian Cancer, Pancreatic Cancer, NSCLC, Breast Cancer, Bladder Cancer

Dosage
1000 mg per vial, as prescribed

Dosage Guidelines
As directed by physician

Suitable For
Adults

Quantity
Single Dose Vial Unit

Storage Instructions
Store below 25C, protect from light

Prescription Category
Rx Only

Single/Multidose
Single Dose

Strength
1000 mg

Reconstitution Required
Yes

Route
IV

Administration
Intravenous

Sterility
Sterile

Gemcitabine Injection Ip Trade Information

Minimum Order Quantity
4 Vials

Supply Ability
500 Vials Per Month

Delivery Time
1 Week

Gemcitabine Injection Ip About

Spotlight your cancer care regimen with AMGICIN-1000, the new formidable ally in oncology. This top-drawer Gemcitabine Injection IP 1000 mg vial unlocks advanced, crackerjack performance for the treatment of ovarian, pancreatic, NSCLC, breast, and bladder cancers. Each sterile, single-dose vial contains lyophilized Gemcitabine IP, requiring reconstitution for intravenous administration. Manufactured in India, AMGICIN-1000 is a prescription-only cytotoxic agent specifically recommended for adults. Adhering to strict storage and usage guidelines, AMGICIN-1000 stands as a vanguard in cancer care, ensuring precision and reliability for each treatment cycle.

Exceptional Features & Application of Gemcitabine Injection IP

AMGICIN-1000 is crafted with a focus on material excellence, featuring highly purified lyophilized Gemcitabine IP powder. Its single-dose, sterile vial is designed for adult patients and delivers top-drawer anticancer efficacy. Best suited for advanced medical settings such as hospitals and oncology centers, this formulation maximizes therapeutic impact. The reconstitution requirement ensures precise dosing, while the robust packaging protects from light and maintains potency, tailored for streamlined intravenous administration under clinical supervision.

Distribution, Export Markets & Transaction Assurance

AMGICIN-1000 is widely available throughout the main domestic market in India and is exported to global markets for comprehensive cancer care. Extensive logistics networks are employed to ensure secure shipping and optimal product valuation. Reliable supply chains support timely fulfillment of both local and international orders. Flexible payment terms cater to diverse client needs, prioritizing secure transactions. Each shipment is meticulously packaged with a single vial per box, preserving product integrity from manufacturer to medical facility.

FAQ's of Gemcitabine Injection Ip:

Q: How should Gemcitabine Injection IP (AMGICIN-1000) be administered?

A: Gemcitabine Injection IP is administered intravenously. The lyophilized powder must be reconstituted and given as an infusion by a healthcare professional in a clinical setting.

Q: What cancers is AMGICIN-1000 recommended for?

A: AMGICIN-1000 is indicated for the treatment of ovarian, pancreatic, non-small cell lung cancer (NSCLC), breast, and bladder cancers, as prescribed by a physician.

Q: When should the dosage of Gemcitabine Injection IP be determined?

A: Dosage guidelines should always be determined and adjusted by the treating physician, based on the individual patient's condition and specific medical requirements.

Q: Where should AMGICIN-1000 be stored before use?

A: Store AMGICIN-1000 below 25C, avoiding exposure to light. Always check the expiry date and keep the vial in its original packaging until ready for reconstitution and administration.

Q: What is the process for preparing and using AMGICIN-1000?

A: AMGICIN-1000 requires reconstitution with sterile water prior to intravenous injection. The preparation and administration process must be performed by qualified healthcare staff following recommended medical protocols.

Q: What are the benefits of choosing AMGICIN-1000 for cancer treatment?

A: AMGICIN-1000 delivers reliable, top-drawer efficacy with international standards of sterility and purity. It provides targeted action for various cancers, supported by robust clinical use and secure, quality-assured packaging.

Tell us about your requirement